RPG Life Sciences' (NSE:RPGLIFE, BOM:532983) profit surged to 1.17 billion Indian rupees in the fiscal fourth quarter ended March 31 against 132.4 million rupees a year ago.
Earnings per share climbed to 70.96 rupees compared with the year-ago figure of 8.01 rupees, according to a Monday filing to the Indian stock exchanges by the pharmaceuticals manufacturer.
Revenue from operations in fiscal Q4 increased to 1.43 billion rupees from 1.27 billion rupees a year earlier.
The board of directors recommended a final dividend of 20 rupees per equity share of the face value of 8 rupees each for the fiscal year ended March 31.
A special dividend of 4 rupees per equity share of face value of 8 rupees each has also been recommended on account of significant exceptional profit on the assignment of land.
The company's shares were up nearly 3% in recent trade.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。